Overview

Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).
Phase:
Phase 1
Details
Lead Sponsor:
Puma Biotechnology, Inc.
Treatments:
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination